In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Relation and Novartis collaborate to advance treatments for atopic diseases using AI and immuno-dermatology expertise. Relation receives $55 million upfront, with potential milestones up to $1.7 ...

Members of the far-right group Patriot Front march through Washington, DC, on May 13, 2023. Nathan Posner/Anadolu Agency via Getty Images For CFR’s annual Preventive Priorities Survey, U.S. foreign ...

SINCE its first announcement by Dr. E. P. Hubble in 1929, the existence of a linear relation between Velocity’ and distance among the extra-galactic nebulae has excited a great deal of theoretical ...

You might have noticed more people taking a pass on alcohol as they discover the physical and mental benefits of an alcohol-free lifestyle. With this trend has come a new generation of nonalcoholic ...

Since 1996, conflict in eastern DRC has led to approximately six million deaths. The First Congo War (1996–1997) began in the wake of the 1994 Rwandan Genocide, during which ethnic Hutu extremists ...